Stiff knees and aching hips may seem like an inevitable part of aging, but experts say we’re getting osteoarthritis all wrong. Despite affecting nearly 600 million people worldwide — and potentially a ...
Symptoms of an overactive bladder include frequent urination, urgency and sometimes incontinence. (A urine infection needs to be ruled out first.) An OAB can sometimes be mistaken for prostate ...
Dear Dr. Roach: My son, age 52, had recent lab results showing that his Lipoprotein (a) level was elevated, at 172 nmol/L. He is in very good health after a recent ablation for atrial fibrillation. We ...
Cystic fibrosis treatments are improving patients’ quality of life. Three physicians from University of Iowa Health Care share more about cystic fibrosis.
Colorectal cancer is highly treatable when caught early—and FIT tests make screening easier than ever with a simple at‑home ...
The Food and Drug Administration aims to evaluate treatments for rare diseases based on plausible evidence that they would work — without requiring a clinical trial first.
Artificial intelligence in medicine is no longer a distant idea. It is already part of hospitals, clinics, and research labs.
A diagnosis of Kaposi sarcoma is a significant life event, but it is a manageable condition. Because KS is so closely linked to immune function, your treatment will likely involve a collaborative ...
Popular GLP-1 weight-loss medications have helped millions of people shed pounds, but new research from Australia.
A genetics‑guided small molecule called compound 6 gently turns down an overactive immune pathway (CARD9), offering a more precise, durable, and potentially safer treatment strategy for Crohn’s ...
Feb 5 (Reuters) - (This Feb 5 story has been corrected to fix Prolia's 2025 sales to $4.4 billion, not $1.05 billion, in paragraph 5) Sign up here. Its pharmacy benefit management unit, Caremark, will ...
To share your story, or find out how to get involved with CNBC Cures, email CNBC.cures@cnbc.com Susannah Rosen was diagnosed with a KIF1A gene mutation at the age of 2½. Patients diagnosed with severe ...